Loading
Life sciences · Journal article
Cell Communication and Signaling · October 14, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Neutrophil extracellular traps (NETs) are web-like structures released by neutrophils, consisting of a DNA backbone embedded with histones and granular enzymes. Initially identified as an antimicrobial defense mechanism, NETs have increasingly attracted attention in recent years for their roles in various non-infectious diseases, particularly central nervous system (CNS) disorders. This review systematically elaborates on the mechanisms underlying NET formation and their bidirectional interactions with neuroinflammation. It highlights the critical involvement of NETs in the progression of diseases such as glioma, brain metastases, stroke, traumatic brain injury, and Alzheimer's disease through core pathways including disruption of the blood–brain barrier, promotion of thromboinflammation, mediation of immunosuppression, and direct neuronal damage. We further summarize potential therapeutic strategies targeting NETs and discuss their prospects as disease biomarkers. By organizing the field around shared neurovascular modules and disease-specific branches, and by distinguishing preclinical promise from human evidence, this review provides a translational framework for prioritizing NET-related biomarkers and therapeutic strategies in neurological diseases.